Back
Novo Nordisk AS Stock Price Chart
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
NVO
Novo Nordisk AS
Last Price:
127.73
Seasonality Move:
4.32%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.
Novo Nordisk AS Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 134.03 | Sell |
| 20-day SMA: | 134.27 | Sell |
| 50-day SMA: | 133.19 | Sell |
| 200-day SMA: | 126.01 | Buy |
| 8-day EMA: | 132.67 | Sell |
| 20-day EMA: | 133.56 | Sell |
| 50-day EMA: | 134.01 | Sell |
| 200-day EMA: | 124.88 | Buy |
Novo Nordisk AS Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.53 | Sell |
| Relative Strength Index (14 RSI): | 40.25 | Sell |
| Chaikin Money Flow: | -1696867 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (131.84 - 137.22) | Sell |
| Bollinger Bands (100): | (129.39 - 140.77) | Sell |
Novo Nordisk AS Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Novo Nordisk AS Stock
Is Novo Nordisk AS Stock a Buy?
- Novo Nordisk AS share price is 127.51 while NVO 8-day simple moving average is 134.03, which is a Sell signal.
- The stock price of NVO is 127.51 while Novo Nordisk AS 20-day SMA is 134.27, which makes it a Sell.
- Novo Nordisk AS 50-day simple moving average is 133.19 while NVO share price is 127.51, making it a Sell technically.
- NVO stock price is 127.51 and Novo Nordisk AS 200-day simple moving average is 126.01, creating a Buy signal.
NVO Technical Analysis vs Fundamental Analysis
Sell
39
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy or a Sell?
-
Novo Nordisk AS stock is rated a Sell
The current Novo Nordisk AS [NVO] share price is $127.51. The Score for NVO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Novo Nordisk AS Stock Info
Market Cap:
567.6B
Price in USD:
127.51
Share Volume:
9.63M
Novo Nordisk AS 52-Week Range
52-Week High:
148.15
52-Week Low:
86.96
Sell
39
Novo Nordisk AS (NVO)
is a Sell
Novo Nordisk AS Share Price Forecast
-
What is the Novo Nordisk AS stock price today?
The Novo Nordisk AS stock price is 127.51 USD today. -
Will NVO stock go up or go down?
Novo Nordisk AS> share price is forecast to RISE/FALL based on technical indicators -
Is Novo Nordisk AS overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk AS is overvalued.
Is Novo Nordisk AS Stock a Buy?
- Novo Nordisk AS share price is 127.51 while NVO 8-day exponential moving average is 132.67, which is a Sell signal.
- The stock price of NVO is 127.51 while Novo Nordisk AS 20-day EMA is 133.56, which makes it a Sell.
- Novo Nordisk AS 50-day exponential moving average is 134.01 while NVO share price is 127.51, making it a Sell technically.
- NVO stock price is 127.51 and Novo Nordisk AS 200-day simple moving average is 124.88, creating a Buy signal.
Fundamental Analysis of Novo Nordisk AS
Is Novo Nordisk AS a good investment?
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.91 per share.
Technical Analysis of Novo Nordisk AS
Should I short Novo Nordisk AS stock?
- NVO Moving Average Covergence Divergence (MACD) indicator is -0.53, suggesting Novo Nordisk AS is a Sell
- Novo Nordisk AS Relative Strength Index (RSI) is 40.25, which suggest Novo Nordisk AS is oversold
- The Bollinger Bands (25) for Novo Nordisk AS is (131.84 - 137.22), which suggest Novo Nordisk AS is a Sell
- The Bollinger Bands (100) for Novo Nordisk AS is (129.39 - 140.77), which suggest Novo Nordisk AS is a Sell
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.